Home Cart 0 Sign in  
X

[ CAS No. 4002-81-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 4002-81-7
Chemical Structure| 4002-81-7
Chemical Structure| 4002-81-7
Structure of 4002-81-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 4002-81-7 ]

Related Doc. of [ 4002-81-7 ]

Alternatived Products of [ 4002-81-7 ]

Product Details of [ 4002-81-7 ]

CAS No. :4002-81-7 MDL No. :MFCD00649915
Formula : C4H4Br2N2 Boiling Point : -
Linear Structure Formula :- InChI Key :DBFMQNPRKMLHLK-UHFFFAOYSA-N
M.W : 239.90 Pubchem ID :2773364
Synonyms :

Calculated chemistry of [ 4002-81-7 ]

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.25
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 38.95
TPSA : 28.68 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.34 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.52
Log Po/w (XLOGP3) : 2.0
Log Po/w (WLOGP) : 2.24
Log Po/w (MLOGP) : 1.21
Log Po/w (SILICOS-IT) : 2.86
Consensus Log Po/w : 1.97

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.05
Solubility : 0.214 mg/ml ; 0.000892 mol/l
Class : Soluble
Log S (Ali) : -2.23
Solubility : 1.42 mg/ml ; 0.0059 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.33
Solubility : 0.111 mg/ml ; 0.000465 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.14

Safety of [ 4002-81-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 4002-81-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 4002-81-7 ]

[ 4002-81-7 ] Synthesis Path-Downstream   1~3

  • 2
  • [ 4002-81-7 ]
  • [ 144581-86-2 ]
  • 2-(4,5-dibromo-2-methyl-1H-imidazole-1-yl)-N-(4-methoxybenzyl)acetamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
90% Stage #1: 4,5-Dibromo-2-methylimidazole With sodium hydride In tetrahydrofuran at 0℃; for 0.25h; Inert atmosphere; Stage #2: α-Bromo-N-p-methoxybenzylacetamide In tetrahydrofuran at 0 - 20℃; for 24h; Inert atmosphere;
  • 3
  • [ 693-98-1 ]
  • [ 4002-81-7 ]
  • [ 16265-11-5 ]
YieldReaction ConditionsOperation in experiment
1: 71% 2: 26% With potassium (aquo)(2‑chlorobenzoato)oxodiperoxo–tungstate(VI) dihydrate; potassium bromide In water; acetonitrile at 20℃; Bromination of organic substrates and productanalysis General procedure: In a representative procedure, organic substrates (1.0 mmol)were added to a solution of acetonitrile/water (1:1, 8 cm3)containing KBr (2 mmol). An accurately weighed amount ofcompound 2 (1.0 mmol) was added to the reaction mixtureat room temperature with continuous stirring. Stirring wascontinued for a further period of ca. 4-5 h. The completionof the reaction was monitored by thin-layer chromatography(TLC). The reaction products as well as the unreactedorganic substrates were separated by column chromatography.The reaction products were analyzed by GC-MS usingbenzophenone as internal standard.
With potassium(aquo)(5-chlorosalicylato)oxodiperoxotungstate(VI) monohydrate; potassium bromide In water; acetonitrile at 20℃; 2.4.1. Representative procedure General procedure: Organic substrate (1.0 mmol) was added to acetonitrile/water (1:1,10 cm3) solution containing KBr (2 mmol). A known amount of solidpotassium(aquo)(5-chlorosalicylato)oxodiperoxotungstate(VI)monohydrate, K[WO(O2)2(5-chlorosalicylato)(H2O)]H2O (1.0 mmol) was added to the reaction mixture with continuous stirring at roomtemperature. Stirring was continued for a further for a period of ~ 4-5 h.The progress of the reaction was monitored by thin-layer chromatography(TLC). The reaction product and the unreacted organic substrateswere separated by column chromatography. The products were analyzedby GC-MS and benzophenone was used as internal standard.
Same Skeleton Products
Historical Records